Merck | MRK - Interest Expense On Debt


Merck reported EUR119M in Interest Expense on Debt for its fiscal quarter ending in September of 2026.





Interest Expense On Debt Change Date
Adidas EUR 80M 22M Sep/2026
Adyen EUR 4.31M 135K Jun/2026
Akzo Nobel EUR 68M 26M Jun/2025
Alcon AG USD 53M 1000K Jun/2026
Amadeus IT EUR 25.3M 5M Sep/2026
Amarin USD 3K 5K Dec/2024
AstraZeneca USD 371M 31M Sep/2026
BASF EUR 229M 7M Sep/2026
Bayer EUR 675M 87M Dec/2025
Beiersdorf EUR 14M 6.5M Jun/2026
Covestro EUR 33M 1000K Sep/2025
Danone EUR 252M 6M Dec/2025
Fresenius EUR 81M 5M Sep/2025
Fresenius Medical Care EUR 97.5M 14.5M Sep/2026
Genmab DKK 139M 129M Jun/2026
Givaudan CHF 58M 7M Dec/2025
GlaxoSmithKline GBP 219M 98M Sep/2026
GRIFOLS EUR 141.43M 61.28M Jun/2025
Hikma Pharmaceutical USD 67M 47M Dec/2025
Infineon EUR 102M 24M Sep/2026
Lakefront Biotherapeutics EUR 1.72M 940K Sep/2025
Linde USD 71M 7M Sep/2026
Lonza CHF 84M 14M Jun/2025
Merck EUR 119M 18M Sep/2026
Novartis USD 468M 6M Sep/2026
Philips EUR 84M 1000K Sep/2026
Roche Holding CHF 304M 7.5M Jun/2025
Sanofi EUR 222M 65M Sep/2026
UCB EUR 49M 29M Dec/2025